Medartis Holding AG

SWX:MED Voorraadrapport

Marktkapitalisatie: CHF 728.7m

Medartis Holding Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Matthias Schupp

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOless than a year
Eigendom CEOn/a
Management gemiddelde ambtstermijn3.7yrs
Gemiddelde ambtstermijn bestuur3.6yrs

Recente managementupdates

Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

Apr 11
Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

Recent updates

Medartis Holding (VTX:MED) Has A Rock Solid Balance Sheet

Nov 09
Medartis Holding (VTX:MED) Has A Rock Solid Balance Sheet

The Strong Earnings Posted By Medartis Holding (VTX:MED) Are A Good Indication Of The Strength Of The Business

Aug 27
The Strong Earnings Posted By Medartis Holding (VTX:MED) Are A Good Indication Of The Strength Of The Business

Medartis Holding AG (VTX:MED) Doing What It Can To Lift Shares

Aug 21
Medartis Holding AG (VTX:MED) Doing What It Can To Lift Shares

When Should You Buy Medartis Holding AG (VTX:MED)?

May 10
When Should You Buy Medartis Holding AG (VTX:MED)?

Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

Apr 11
Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence

Feb 14
The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence

Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

Oct 24
Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

Is Medartis Holding (VTX:MED) A Risky Investment?

Oct 03
Is Medartis Holding (VTX:MED) A Risky Investment?

Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value

Sep 06
Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value

Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)

Jun 21
Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)

Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital

Jan 31
Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital

Why Medartis Holding AG (VTX:MED) Could Be Worth Watching

Oct 30
Why Medartis Holding AG (VTX:MED) Could Be Worth Watching

These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat

Sep 07
These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat

When Should You Buy Medartis Holding AG (VTX:MED)?

Jul 29
When Should You Buy Medartis Holding AG (VTX:MED)?

Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

May 06
Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?

Feb 08
At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?

Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

Jan 18
Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt

Nov 10
We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt

Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

Sep 29
Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital

Jun 08
Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital

How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?

Mar 16
How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?

We're Watching These Trends At Medartis Holding (VTX:MED)

Feb 09
We're Watching These Trends At Medartis Holding (VTX:MED)

Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain

Jan 04
Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain

What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?

Nov 19
What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?

CEO

Matthias Schupp (60 yo)

less than a year

Tenure

Mr. Matthias Schupp is CEO & Member of the Executive Management Board of Medartis Holding AG from 2024. He had been Chief Executive Officer of Neodent at Straumann Holding AG since 2015 until 2024 and serv...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Thomas Straumann
Founder & Vice Chairman26.8yrsCHF 291.97k41.37%
CHF 301.5m
Matthias Schupp
CEO & Member of the Executive Management Boardless than a yeargeen gegevensgeen gegevens
Dirk Kirsten
CFO & Member of the Executive Management Board3.7yrsgeen gegevens0.029%
CHF 212.9k
Mareike Loch
VP of EMEA & Member of Executive Management Board4.3yrsgeen gegevens0.053%
CHF 389.4k
Manuel Schaer
CTO & Member of the Executive Board4yrsgeen gegevens0.017%
CHF 123.7k
Mario Casa
COO & Member of Management Board2.8yrsgeen gegevens0.0027%
CHF 19.5k
Inge Maes
Chief Human Resources Officer & Executive Management Board Memberno datageen gegevensgeen gegevens
Anisha Wharton
Head of Regulatory Affairs3.7yrsgeen gegevensgeen gegevens

3.7yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van MED wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Thomas Straumann
Founder & Vice Chairman26.8yrsCHF 291.97k41.37%
CHF 301.5m
Damien Tappy
Independent Non-Executive Director6.8yrsCHF 188.29k0.19%
CHF 1.4m
Marco Gadola
Independent Chairman4.6yrsCHF 568.06k0.065%
CHF 473.9k
Ciro Roemer
Independent Director2.6yrsCHF 112.76k0.0096%
CHF 70.2k
Willi Miesch
Independent Non Executive Director14.8yrsCHF 161.68k4.55%
CHF 33.1m
Martha Shadan
Independent Non-Executive Directorless than a yeargeen gegevensgeen gegevens
Jennifer Dean
Independent Non-Executive Directorless than a yeargeen gegevensgeen gegevens
Nadia Schmidt
Independent Director2.6yrsCHF 171.53k0.0072%
CHF 52.6k

3.6yrs

Gemiddelde duur

60.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van MED wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.6 jaar).